Abstract:
Porous craniomaxillofacial implants may include a plurality of polymeric particles sintered together at a plurality of contact points to form a porous network having pores; and an antioxidant disposed on a surface of at least some of the polymeric particles and/or in the pore of the porous network, so as to stabilize the implants from at least some oxidative damage during storage, transportation, and/or implementation (in vivo and/or ex vivo). Preferably, the polymeric particles include at least one of polyethylene, a polyethylene-polypropylene copolymer, a polyethylene-polybutylene copolymer, polytetrafluoroethylene, and expanded polytetrafluoroethylene.
Abstract:
A molded polyethylene component that comprises polyethylene having a melt flow index of about 3.5 g/10 min or greater as measured by ASTM D1238 at 190° C./21.5 kg weight and having an ash content of about 500 ppm or less may be useful biomedical devices, including kits and methods relating thereto.
Abstract:
An implantable medical device that employs one or more fibers formed from a polymer composition that contains at least one liquid crystalline polymer is provided. In addition to being highly inert and biocompatible, the rigid rod-like structure of liquid crystalline polymers can allow them to be particularly well suited for implantable devices. Apart from the benefits from the polymer itself, the fibers are formed in such a manner so that they are generally flexible, but yet still possess a sufficient degree of strength so that they can be effectively employed in implantable medical devices.